ReShape Lifesciences, Inc.

Q1 2024 13F Holders

Symbol
RSLS
CUSIP
76090R200
Type
Equity
Class
COM
Num filings
21
Total reported value, excl. options
$49.1 k
Manager Report Date Value ($000) Shares Option Type